Pulse Biosciences, Inc. (PLSE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 10.58 |
| Open | 10.61 |
| Bid | 9.94 x 200 |
| Ask | 10.05 x 200 |
| Day's range | 9.81 - 10.61 |
| 52-week range | 3.78 - 14.96 |
| Volume | |
| Avg. volume | 224,911 |
| Market cap | 562.739M |
| Beta (5Y monthly) | 1.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.79 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.A US$60m drop in the market cap of Pulse Biosciences, Inc. (NASDAQ:PLSE) is not what insiders like to see after purchasing shares recently
Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable...
- Simply Wall St.
President & CEO of Pulse Biosciences Burke Barrett Buys More Stock
Even if it's not a huge purchase, we think it was good to see that Burke Barrett, the President & CEO of Pulse...
Business WirePulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
HAYWARD, Calif., May 20, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that the Company’s Board of Directors has determined a new record date for the Company’s previously announced rights offering (the "Rights Offering"), which will be available to all holders of record of the Company’s common stock, par value $0.001 per share (the "Common Stock
© 2024 Yahoo. All rights reserved.